Banque Cantonale Vaudoise’s Inovio Pharmaceuticals INO Stock Holding History

Banque Cantonale Vaudoise’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Hold	0	–	–	–	1028
2023 Q4	–	Hold	0	–	–	–	1113
2023 Q3	–	Sell	-174	Closed	-$961	–	1192
2023 Q2	$1K	Hold	174	–	–	﹤0.01%	1166
2023 Q1	$2K	Hold	174	–	–	﹤0.01%	1166
2022 Q4	$3K	Hold	174	–	–	﹤0.01%	1160
2022 Q3	$4K	Sell	174 -3	-2%	-$77	﹤0.01%	1194
2022 Q2	$4K	Buy	177 +3	+2%	+$85	﹤0.01%	1233
2022 Q1	$7K	Sell	174 -308	-64%	-$13.9K	﹤0.01%	1232
2021 Q4	$29K	Sell	482 -781	-62%	-$62.6K	﹤0.01%	1147
2021 Q3	$108K	Sell	1,263 -34	-3%	-$3.41K	﹤0.01%	926
2021 Q2	$144K	Buy	1,297 +3	+0.2%	+$288	0.01%	900
2021 Q1	$144K	Sell	1,294 -16	-1%	-$2.1K	0.01%	838
2020 Q4	$139K	Buy	1,310 +79	+6%	+$10.5K	0.01%	799
2020 Q3	$171K	Buy	1,231 +578	+89%	+$121K	0.01%	725
2020 Q2	$211K	Buy	+653	New	+$105K	0.02%	638
2020 Q1	–	Hold	0	–	–	–	931
2019 Q4	–	Hold	0	–	–	–	897

Other funds holding INO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Banque Cantonale Vaudoise's INO Position: Q1 2024 in Review

Banque Cantonale Vaudoise held its Inovio Pharmaceuticals (INO) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1028.

Banque Cantonale Vaudoise first reported a position in INO in Q2 2020 and has held it in 13 quarters since. The position peaked at $211K in Q2 2020. 89 funds tracked by Wall St. Rank hold INO as of Q1 2024.

Banque Cantonale Vaudoise held 0 shares of Inovio Pharmaceuticals worth $0 as of Q1 2024.
Banque Cantonale Vaudoise left its Inovio Pharmaceuticals share count unchanged in Q1 2024.
Inovio Pharmaceuticals made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q1 2024, its #1028 holding.
Banque Cantonale Vaudoise first reported a position in Inovio Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
Banque Cantonale Vaudoise's Inovio Pharmaceuticals position peaked at $211K in Q2 2020.
89 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2024, filed 10 Apr 2024.